|
1
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Parr SK and Siew ED: Delayed consequences
of acute kidney injury. Adv Chronic Kidney Dis. 23:186–194.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Yu CC, Chien CT and Chang TC: M2
macrophage polarization modulates epithelial-mesenchymal transition
in cisplatin-induced tubulointerstitial fibrosis. Biomedicine
(Taipei). 6(5)2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Qi W, Chen X, Poronnik P and Pollock CA:
The renal cortical fibroblast in renal tubulointerstitial fibrosis.
Int J Biochem Cell Biol. 38:1–5. 2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
El-Naga RN: Pre-treatment with cardamonin
protects against cisplatin-induced nephrotoxicity in rats. Impact
on NOX-1, inflammation and apoptosis. Toxicol Appl Pharmacol.
274:87–95. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Qi ZL, Wang Z, Li W, Hou JG, Liu Y, Li XD,
Li HP and Wang YP: Nephroprotective effects of anthocyanin from the
fruits of Panax ginseng (GFA) on Cisplatin-induced acute kidney
injury in mice. Phytother Res. 31:1400–1409. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Nangaku M, Rosenberger C, Heyman SN and
Eckardt KU: Regulation of hypoxia-inducible factor in kidney
disease. Clin Exp Pharmacol Physiol. 40:148–157. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kim IH, Kwon MJ, Jung JH and Nam TJ:
Protein extracted from Porphyra yezoensis prevents
cisplatin-induced nephrotoxicity by downregulating the MAPK and
NF-κB pathways. Int J Mol Med. 41:511–520. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Thongnuanjan P and Soodvilai S,
Chatsudthipong V and Soodvilai S: Fenofibrate reduces
cisplatin-induced apoptosis of renal proximal tubular cells via
inhibition of JNK and p38 pathways. J Toxicol Sci. 41:339–349.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liang X, Yang Y, Huang Z, Zhou J, Li Y and
Zhong X: Panax notoginseng saponins mitigate cisplatin induced
nephrotoxicity by inducing mitophagy via HIF-1α. Oncotarget.
8:102989–103003. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu X, Huang Z, Zou X, Yang Y, Qiu Y and
Wen Y: Possible mechanism of PNS protection against
cisplatin-induced nephrotoxicity in rat models. Toxicol Mech
Methods. 25:347–354. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li X, Lu L, Chen J, Zhang C, Chen H and
Huang H: New Insight into the mechanisms of ginkgo Biloba extract
in vascular aging prevention. Curr Vasc Pharmacol. 18:334–345.
2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
EGb 761. Ginkgo biloba extract, Ginkor.
Drugs R D. 4:188–193. 2003.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gevrek F, Biçer Ç, Kara M and Erdemir F:
The ameliorative effects of Ginkgo biloba on apoptosis, LH-R
expression and sperm morphology anomaly in testicular torsion and
detorsion. Andrologia: Feb 7, 2018 (Epub ahead of print).
|
|
15
|
Wang A, Yang Q, Li Q, Wang X, Hao S, Wang
J and Ren M: Ginkgo Biloba L. Extract reduces H2O2-induced bone
marrow mesenchymal stem cells cytotoxicity by regulating
mitogen-activated protein kinase (MAPK) signaling pathways and
oxidative stress. Med Sci Monit. 24:3159–3167. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang R, Zhang H, Wang Y, Song F and Yuan
Y: Inhibitory effects of quercetin on the progression of liver
fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and
Bcl-2/Bax signaling. Int Immunopharmacol. 47:126–133.
2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li Y, Xiong Y, Zhang H, Li J, Wang D, Chen
W, Yuan X, Su Q, Li W, Huang H, et al: Ginkgo biloba extract GBE761
attenuates brain death-induced renal injury by inhibiting
pro-inflammatory cytokines and the SAPK and JAK-STAT signalings.
Sci Rep. 7(45192)2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cao CJ, Su Y, Sun J, Wang GY, Jia XQ, Chen
HS and Xu AH: Anti-tumor effect of ginkgo biloba exocarp extracts
on B16 melanoma bearing mice involving P I3K/Akt/HIF-1α/VEGF
signaling pathways. Iran J Pharm Res. 18:803–811. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yang YF, Lao S, Luo M and Zeng J: Dynamic
observation of the protective effect of ginkgo biloba extract on
cisplatin kidney damage in rabbits. Lishizhen Medicine and Materia
Medica. 22:2897–2898. 2011.
|
|
20
|
Wei W, Wu XM and Li YJ: Experimental
Methodology of Pharmacology. 4th edition. People's Medical
Publishing House, Beijing, pp1439-1442, 2010.
|
|
21
|
Asaad GF, Hassan A and Mostafa RE:
Anti-oxidant impact of Lisinopril and Enalapril against acute
kidney injury induced by doxorubicin in male Wistar rats:
Involvement of kidney injury molecule-1. Heliyon.
7(e05985)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sun N, Zhai L, Li H, Shi LH, Yao Z and
Zhang B: Angiotensin-converting enzyme inhibitor (ACEI)-mediated
amelioration in renal fibrosis involves suppression of mast cell
degranulation. Kidney Blood Press Res. 41:108–118. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ražná K, Sawinska Z, Ivanišová E, Vukovic
N, Terentjeva M, Stričík M, Kowalczewski PŁ, Hlavačková L, Rovná K,
Žiarovská J and Kačániová M: Properties of Ginkgo biloba L.:
Antioxidant characterization, antimicrobial activities, and genomic
MicroRNA based marker fingerprints. Int J Mol Sci.
21(3087)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lu Q, Zuo WZ, Ji XJ, Zhou YX, Liu YQ, Yao
XQ, Zhou XY, Liu YW, Zhang F and Yin XX: Ethanolic Ginkgo biloba
leaf extract prevents renal fibrosis through Akt/mTOR signaling in
diabetic nephropathy. Phytomedicine. 22:1071–1078. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yang H, Zhang W, Xie T, Wang X and Ning W:
Fluorofenidone inhibits apoptosis of renal tubular epithelial cells
in rats with renal interstitial fibrosis. Braz J Med Biol Res.
52(e8772)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Li A, Zhang X, Shu M, Wu M, Wang J, Zhang
J, Wang R, Li P and Wang Y: Arctigenin suppresses renal
interstitial fibrosis in a rat model of obstructive nephropathy.
Phytomedicine. 30:28–41. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yuan JS, Reed A, Chen F and Stewart CN Jr:
Statistical analysis of real-time PCR data. BMC Bioinformatics.
7(85)2006.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yamamoto Y, Watanabe K, Tsukiyama I,
Matsushita H, Yabushita H, Matsuura K and Wakatsuki A:
Nephroprotective effects of hydration with magnesium in patients
with cervical cancer receiving cisplatin. Anticancer Res.
35:2199–2204. 2015.PubMed/NCBI
|
|
29
|
Li Q, Liang X, Yang Y, Zeng X, Zhong X and
Huang C: Panax notoginseng saponins ameliorate cisplatin-induced
mitochondrial injury via the HIF-1α/mitochondria/ROS pathway. FEBS
Open Bio. 10:118–126. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lu S, Zhong X, Yang Y, Zou X, Liang X and
Cai G: Effects of single dose of cisplatin on renal interstitial
fibrosis indicators in rats. China Pharmacy. 29:298–302. 2018.
|
|
31
|
Johnson FL, Patel NSA, Purvis GSD, Chiazza
F, Chen J, Sordi R, Hache G, Merezhko VV, Collino M, Yaqoob MM and
Thiemermann C: Inhibition of IκB kinase at 24 hours after acute
kidney injury improves recovery of renal function and attenuates
fibrosis. J Am Heart Assoc. 6(e005092)2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ozkok A and Edelstein CL: Pathophysiology
of cisplatin-induced acute kidney injury. Biomed Res Int.
2014(967826)2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Pabla N and Dong Z: Cisplatin
nephrotoxicity: Mechanisms and renoprotective strategies. Kidney
Int. 73:994–1007. 2008.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Pabla N and Dong Z: Curtailing side
effects in chemotherapy: A tale of PKCδ in cisplatin treatment.
Oncotarget. 3:107–111. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Huang SJ, Huang J, Yan YB, Qiu J, Tan RQ,
Liu Y, Tian Q, Guan L, Niu SS, Zhang Y, et al: The renoprotective
effect of curcumin against cisplatin-induced acute kidney injury in
mice: Involvement of miR-181a/PTEN axis. Ren Fail. 42:350–357.
2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lee IC, Ko JW, Park SH, Shin NR, Shin IS,
Kim YB and Kim JC: Ameliorative effects of pine bark extract on
cisplatin-induced acute kidney injury in rats. Ren Fail.
39:363–371. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tian J, Liu Y and Chen K: Ginkgo biloba
extract in vascular protection: Molecular mechanisms and clinical
applications. Curr Vasc Pharmacol. 15:532–548. 2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wang Y, Pei DS, Ji HX and Xing SH:
Protective effect of a standardized Ginkgo extract (ginaton) on
renal ischemia/reperfusion injury via suppressing the activation of
JNK signal pathway. Phytomedicine. 15:923–931. 2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Sener G, Sener E, Sehirli O, Oğünç AV,
Cetinel S, Gedik N and Sakarcan A: Ginkgo biloba extract
ameliorates ischemia reperfusion-induced renal injury in rats.
Pharmacol Res. 52:216–222. 2005.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Gulec M, Iraz M, Yilmaz HR, Ozyurt H and
Temel I: The effects of ginkgo biloba extract on tissue adenosine
deaminase, xanthine oxidase, myeloperoxidase, malondialdehyde, and
nitric oxide in cisplatin-induced nephrotoxicity. Toxicol Ind
Health. 22:125–130. 2006.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Younis NN, Elsherbiny NM, Shaheen MA and
Elseweidy MM: Modulation of NADPH oxidase and Nrf2/HO-1 pathway by
vanillin in cisplatin-induced nephrotoxicity in rats. J Pharm
Pharmacol. 72:1546–1555. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Jing Z, Hu L, Su Y, Ying G, Ma C and Wei
J: Potential signaling pathway through which Notch regulates
oxidative damage and apoptosis in renal tubular epithelial cells
induced by high glucose. J Recept Signal Transduct Res: Sep 16,
2020 (Epub ahead of print).
|
|
43
|
Zhang XF, Yang Y, Zhang J and Cao W:
Microvesicle-containing miRNA-153-3p induces the apoptosis of
proximal tubular epithelial cells and participates in renal
interstitial fibrosis. Eur Rev Med Pharmacol Sci. 23:10065–10071.
2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Du B, Dai XM, Li S, Qi GL, Cao GX, Zhong
Y, Yin PD and Yang XS: MiR-30c regulates cisplatin-induced
apoptosis of renal tubular epithelial cells by targeting Bnip3L and
Hspa5. Cell Death Dis. 8(e2987)2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wang Y, Wang R, Wang Y, Peng R, Wu Y and
Yuan Y: Ginkgo biloba extract mitigates liver fibrosis and
apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax
signaling. Drug Des Devel Ther. 9:6303–6317. 2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Cuadrado A and Nebreda AR: Mechanisms and
functions of p38 MAPK signalling. Biochem J. 429:403–417.
2010.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Deacon K, Mistry P, Chernoff J, Blank JL
and Patel R: p38 Mitogen-activated protein kinase mediates cell
death and p21-activated kinase mediates cell survival during
chemotherapeutic drug-induced mitotic arrest. Mol Biol Cell.
14:2071–2087. 2003.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Liu Z, Xue L, Liu Z, Huang J, Wen J, Hu J,
Bo L and Yang R: Tumor necrosis factor-like weak inducer of
apoptosis accelerates the progression of renal fibrosis in lupus
nephritis by activating SMAD and p38 MAPK in TGF-β1 signaling
pathway. Mediators Inflamm. 2016(8986451)2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Li ZL, Shi Y, Le G, Ding Y and Zhao Q:
24-week exposure to oxidized tyrosine induces hepatic fibrosis
involving activation of the MAPK/TGF-β1 signaling pathway in
Sprague-Dawley Rats model. Oxid Med Cell Longev.
2016(3123294)2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Liu LL, Li D, He YL, Zhou YZ, Gong SH, Wu
LY, Zhao YQ, Huang X, Zhao T, Xu L, et al: MiR-210 protects renal
cell against hypoxia-induced apoptosis by targeting HIF-1alpha. Mol
Med. 23:258–271. 2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Liu L, Zhang P, Bai M, He L, Zhang L, Liu
T, Yang Z, Duan M, Liu M, Liu B, et al: p53 upregulated by HIF-1α
promotes hypoxia-induced G2/M arrest and renal fibrosis in vitro
and in vivo. J Mol Cell Biol. 11:371–382. 2019.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Liu SQ, Yu JP, Chen HL, Luo HS, Chen SM
and Yu HG: Therapeutic effects and molecular mechanisms of ginkgo
biloba extract on liver fibrosis in rats. Am J Chin Med. 34:99–114.
2006.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Oh JH, Oh J, Togloom A, Kim SW and Huh K:
Effects of ginkgo biloba extract on cultured human retinal pigment
epithelial cells under chemical hypoxia. Curr Eye Res.
38:1072–1082. 2013.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Chen M, Zou W, Chen M, Cao L, Ding J, Xiao
W and Hu G: Ginkgolide K promotes angiogenesis in a middle cerebral
artery occlusion mouse model via activating JAK2/STAT3 pathway. Eur
J Pharmacol. 833:221–229. 2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Singh B, Kaur P, Gopichand Singh RD and
Ahuja PS: Biology and chemistry of Ginkgo biloba. Fitoterapia.
79:401–418. 2008.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Wang T, Xiao J, Hou H, Li P, Yuan Z, Xu H,
Liu R, Li Q and Bi K: Development of an ultra-fast liquid
chromatography-tandem mass spectrometry method for simultaneous
determination of seven flavonoids in rat plasma: Application to a
comparative pharmacokinetic investigation of Ginkgo biloba extract
and single pure ginkgo flavonoids after oral administration. J
Chromatogr B Analyt Technol Biomed Life Sci. 1060:173–181.
2017.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Ji X, Cao J, Zhang L, Zhang Z, Shuai W and
Yin W: Kaempferol protects renal fibrosis through activating the
BMP-7-Smad1/5 signaling pathway. Biol Pharm Bull. 43:533–539.
2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Liu X, Sun N, Mo N, Lu S, Song E, Ren C
and Li Z: Quercetin inhibits kidney fifibrosis and the epithelial
to mesenchymal transition of the renal tubular system involving
suppression of the Sonic Hedgehog signaling pathway. Food Funct.
10:3782–3797. 2019.PubMed/NCBI View Article : Google Scholar
|
